Якість життя в пацієнтів з ішемічною хворобою серця і серцевою недостатністю

О.Й. Жарінов, Н.Б. Іванюк, О.А. Єпанчінцева, Р.М. Вітовський, Б.М. Тодуров

Література 

1. Baleva ES, Aleshkina OYu. Prospects for the study of the quality of life of patients with ischemic heart disease. Bulletin of Medical Internet Conferences. 2011;1(7):43-44. (in Russ.).
2. Voronkov LG, Lutsak O, Babich PM. Predictors of quality of life in patients with chronic heart failure. Ukrainian Medical Journal. 2011;3(83):86-88. (in Ukr.).
3. Kryukov NN, Kachkovsky MA Influence of heart failure on quality of life of patients with myocardial infarction. Russian Heart Failure Journal. 2005;6(4):169-171. (in Russ.).
4. Libis RA, Kots YaI, Ageev FT. Quality of life as a criterion for the successful therapy of patients with chronic heart failure. Russ. Med. J. 1999;2:84-87. (in Russ.).
5. Yagenskyi AV, Höfer S, Sichkaruk IM, Oldridge N. Quality of life assessment in patients with ischemic heart disease: validation of Ukrainian-language version of MacNew Heart Disease Health-related Quality of Life. Ukrainian Cardiology Journal. 2013;3:22-28. (in Ukr.).
6. Brink E, Grankvist G, Karlson BW, Hallberg LR. Health-related quality of life in women and men one year after acute myocardial infarction. Qual. Life Res. 2005;14(3). Р. 749-757.
7. Chaitman BR, Ryan TJ, Kronmal RA, et al. Coronary Artery Surgery Study (CASS): Comparability of 10 year survival in randomized and randomizable patients. J Am Coll Cardiol. 1990;16(5):1071-1078.
8. Chan PS, Soto G, Jones PG, et al. Patient health status and costs in heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation. 2009;119:398-407.
9. Cleland JG, Calvert M, Freemantle N, et al. The Heart Failure Revascularisation Trial (HEART). Eur J Heart Fail. 2011;13(2):227-233.
10. Cohn JN, Tognoni G. A Randomized Trial Of The Angiotensin-Receptor Blocker Valsartan In Chronic Heart Failure. New Engl J. Med. 2001;345(23):1667-1675.
11. Crilley JG, Farrer M. Impact of first myocardial infarction on self-perceived health status. QJM. 2001;94(1):13-18.
12. Dagenais GR, Lu J, Faxon DP, et al. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation. 2011;123(14):1492-1500.
13. De Quadros AS, Lima TC, Rodrigues AP et al. Quality of life and health status after percutaneous coronary intervention in stable angina patients. Cathet Cardiovasc Intervent. 2011;77:954-960.
14. DeVon HA, Ryan CJ, Ochs AL, et al. Symptoms across the continuum of acute coronary syndromes: differences between women and men. Am J Crit Care. 2008;17(1):14-25.
15. Dougherty CM, Dewhurst T, Nichol WP, et al. Comparison of three quality of life instruments in stable angina pectoris: the Seattle Angina Questionnarie (SAQ), the Short Form Health Survey (SF-36) and the Quality of Life IndexCardiacVersion III (QLI). J Clin Epidemiol 1998;51:569-575.
16. Ekici B, Ercan EA, Cehreli S, et al. The effect of emotional status and health-related quality of life on the severity of coronary artery disease. Kardiologia Polska. 2014;72(7):617-623.
17. Favarato ME, Hueb W, Boden WE, et al. Quality of life in patients with symptomatic multivessel coronary artery disease: A comparative post hoc analyses of medical, angioplasty or surgical strategies - MASS II trial. Int J Cardiol. 2007;116(3):364-370.
18. Filade I, Ramos I. Validity and reliability of the SF-36 Health Survey Questionnaire in patients with coronary artery disease. J Clin Epidemiol. 2000;53:359-365.
19. Graham MM, Norris CM, Galbraith PD, et al. Quality of life after coronary revascularization in the elderly. Eur Heart J. 2006;27:1690-1698.
20. Haddock CK, Poston WSC, Taylor JE, et al. Smoking and health outcomes after percutaneous coronary intervention. Am Heart J. 2003;145(4):652-657.
21. Haerer W, Bauer U, Sultan N, et al. Acute and chronic effects of diuretic monoterapy by Piretanide in congestive heart failure - a placebo-controlled trial. Cardiovasc Drugs Ther. 1990;4:515-522.
22. Hak T, Willems D, van der Wal G, et al. A qualitative validation of the Minnesota Living with Heart Failure Questionnaire. Qual. Life Res. 2004;13:417-426.
23. Henderson RA, Pocock SJ, Clayton TC, et al. Seven-year outcome in the RITA-2 trial: Coronary angioplasty versus medical therapy. J Am Coll Cardiol. 2003;42(7):1161-1170.
24. Hjalmarson A, Goldstein S, Fagerberg B. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: MERIT Heart Failure. JAMA. 2000;283:1295-1302.
25. Hobbs FD, Kenkre JE, Roalfe AK, et al. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J. 2002;23(23):1867-1876.
26. Hofer S, Lim L, Guyatt G, Oldridge N. The MacNew Heart Disease health-related quality of life instrument: a summary. Health Qual Life Outcomes. 2004;2:3.
27. Hueb WA, Soares PR, Almeida De Oliveira S, et al. Five-year follow-up of the medicine, angioplasty, or surgery study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis. Circulation. 1999;100:107-113.
28. Jenkinson C, Jenkinson D, Shepperd S. Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and Coop Charts). Age and Ageing. 1997;26:7-13.
29. Kaul P, Lytle BL, Spertus JA, et al. Influence of racial disparities in procedure use on functional status outcomes among patients with coronary artery disease. Circulation. 2005;111:1284-1290.
30. Kimble LP, McGuireb DB, Dunbara SB. Gender differences in pain characteristics of chronic stable angina and perceived physical limitation in patients with coronary artery disease. NIH Public Access. 2003;101(10):45-53.
31. Kosiborod M, Soto GE, Jones PG, et al. Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments. Circulation. 2007;115:1975-1981.
32. Lee GA. Coronary artery disease and quality of life. Baker IDI Heart and Diabetes Institute. Melbourne, Australia, 2010:1-10.
33. Littik ML, Lesman-Leegte I, Jaarsma T. Quality of life and depressive symptoms in heart failure patients and their partners: the impact of role and gender. J Card. Fail. 2009;15(7):580-585.
34. Mark DB, Knight JD, Velazquez EJ, et al. Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: а randomized trial. Ann Intern Med. 2014;161(6):392-399.
35. Marwick TH, Zuchowski C, Lauer MS. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol. 1999;33(3):750-758.
36. Mommersteeg PMC, Denollet J, Spertus JA, et al. Health status as a risk factor in cardiovascular disease: a systematic review of current evidence. Amer Heart J. 2008;10:1-11.
37. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease. The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003.
38. Müller K, Gamba G, Jaquet F. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV - efficacy and quality of life. Eu. J Heart Fail. 2003;5(6):793-801.
39. Najafi M, Sheikhvatan M, Montazeri A et al. Quality of life in coronary artery disease: SF-36 compared to WHOQOL-BREF. J Tehran University Heart Center. 2008;3(2):101-106.
40. Nogueira IDB, Servantes DM, Nogueira PA. de MS. Correlation between quality of life and functional capacity in cardiac failure. Arq Bras Cardiol. 2010;95(2):238-243.
41. Norris CM, Saunders LD, Ghali WA, et al. Health-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical management. Can J Cardiol. 2004;20(12):1259-1266.
42. O’Leary C, Jones P. The left ventricular dysfunction questionnaire (LVD-36): reliability, validity, and responsiveness. Heart. 2000;83(6):634-640.
43. Pelegrino VM, Dantas RAS, Clark AM. Health-related quality of life determinants in outpatients with heart failure, Revista Latino-Americana de Enfermagem. Heart Lung. 2011;19(3):451-457.
44. Pepine CJ. Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials. Cardiology. 2013;7:1-20.
45. Pettersen KI. Health-related quality of life after myocardial infarction: methods for assessment and determinants. Faculty of Medicine, University of Oslo. 2008;689:1-54.
46. Pfisterer M, Buser P, Osswald S, et al. Trial of Invasive versus Medical therapy in Elderly patients (TIME) Investigators. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. JAMA. 2003;289(9):1117-1123.
47. Poblete PF, Kyle MC, Pipberger HV, et al. Effect of treatment on morbidity in hypertension. veterans administration cooperative study on antihypertensive agents. Effect on the electrocardiogram. Circulation. 1973;48:481-490.
48. Pron G. Coronary Revascularization in Ischemic Heart Failure Patients: a rapid review. Health Quality Ontario. 2013;1:28.
49. Rumsfeld JS, Alexander KP, Goff DCJr, Graham MM. Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association. Circulation. 2013;127(22):2233-2249.
50. Rumsfeld JS, MaWhinney S, McCarthy MJr, et al. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. JAMA. 1999;281(14):1298-1303.
51. Sanderson JE, Chan SKW, Yip G. Beta-blockade in heart failure. A comparison of carvedilol with metoprolol. JACC. 1999;34(5):1522-1528.
52. Scarinzi C, Berchialla P, Ghidina M, et al. The Severe Heart Failure Questionnaire: Italian translation and linguistic validation. J. Preventive Medicine and Hygiene. 2008;49(4):152-157.
53. Seki1 S, Kato N, Ito N, et al. Validity and reliability of Seattle Angina Questionnaire japanese version in patients with coronary artery disease. Asian Nursing Research. 2010;4(2):57-63.
54. Spertus JA, Jones P, McDonell M, et al. Health status predicts long-term outcome in outpatients with coronary disease. Circulation. 2002;106:43-49.
55. Spertus JA, Salisbury AC, Jones PG, et al. Predictors of quality-of-life benefit after percutaneous coronary intervention. Circulation. 2004. 110:3789-3794.
56. Spiraki C, Kaitelidou D. Health-related quality of life measurement in patients admitted with coronary heart disease and heart failure to a cardiology department of a secondary urban hospital in Greece. Hellenic J Cardiol. 2008;49:241-247.
57. Taira DA, Seto TB, Ho KKL. Impact of smoking on health-related quality of life after percutaneous coronary revascularization. Circulation. 2000;102:1369-1374.
58. Takiuti ME, Hueb W, Hiscock SB, et al. Quality of life after surgical myocardial revascularization, angioplasty or medical treatment. Arq Bras Cardiol. 2007;88(5):475-481.
59. Tofighi S, Kiadaliri AA, Sadeghifar J, et al. Health-related quality of life among patients with coronary artery disease: a post-treatment follow-up study in Iran. Cardiology Research and Practice. 2012;1-6.
60. Torado JF, Shen BJ, Raffa SD. Prevalence of anxiety disorders in men and women with established coronary heart disease. J Cardiopulmonary Rehabilitation. 2007;27:86-91.
61. Van Jaarsveld CH, Sanderman R, Miedema I, et al. Changes in health-related quality of life in older patients with acute myocardial infarction or congestive heart failure: a prospective study. J Am Geriatr Soc. 2001;49(8):1052-1058.
62. Wadie B, Shaheen S, Nashat E. Quality of life assessment after coronary artery revascularization using coronary revascularization outcome questionnare in ischemic egiptian patients. Med J Cairo Univ. 2013;81(1):1-5.
63. Währborg P, on behalf of the CABRI trialists. Quality of life after coronary angioplasty or bypass surgery. 1-year follow-up in the coronary angioplasty versus bypass revascularization investigation (CABRI) trial. Eur Heart J. 1999;20:653-658.
64. Williams GH. Quality of life and its impact on hypertensive patients. Amer J Med. 1987;82:99-105.
65. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA. 1995;273(1):59-65.
66. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg. 2014;46(4):517-592.
67. Yusuf S, Zucker D, Passamani E, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344(8922):563-570.
68. Zambroski CH, Moser DK, Bhat G, et al. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2005;4(3):198-206.
69. Zellweger MJ, Osterwalder RH, Langewitz W, et al. Coronary artery disease and depression. Eur Heart J. 2004;25:3-9.
70. Zhang Z, Mahoney EM, Stables RH, et al. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery. one-year results from the Stent or Surgery trial. Circulation. 2003;108(14):1694-1700.